©Author(s) (or their employer(s)) 2026.
World J Gastrointest Surg. Feb 27, 2026; 18(2): 113698
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.113698
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.113698
Table 3 Analysis of relevant risk factors, n (%)/mean ± SD
| Non-complication (n = 49) | Complication (n = 25) | t/χ2 | P value | |
| Age (year) | 62.63 ± 10.10 | 61.04 ± 9.33 | 0.658 | 0.513 |
| Gender | ||||
| Male | 27 (55.10) | 15 (60.0) | 0.162 | 0.687 |
| Female | 22 (44.90) | 10 (40.0) | ||
| Tumor diameter (cm) | 1.95 ± 0.80 | 1.93 ± 0.83 | 0.124 | 0.902 |
| Previous abdominal surgery | ||||
| No | 34 (69.39) | 19 (76.0) | 0.356 | 0.551 |
| Yes | 15 (30.61) | 6 (24.0) | ||
| Hypertension | ||||
| No | 31 (63.27) | 14 (56.0) | 0.367 | 0.545 |
| Yes | 18 (36.73) | 11 (44.0) | ||
| Diabetes | ||||
| No | 43 (87.76) | 23 (92.0) | 0.309 | 0.578 |
| Yes | 6 (12.24) | 2 (8.0) | ||
| Coronary heart disease | ||||
| No | 46 (93.88) | 25 (100.0) | 1.595 | 0.207 |
| Yes | 3 (6.12) | 0 | ||
| CBC (24 h postoperatively) | ||||
| Hemameba | 8.60 ± 3.44 | 10.81 ± 4.51 | -2.354 | 0.021 |
| Hemoglobin | 127.96 ± 18.12 | 124.28 ± 15.65 | 0.863 | 0.391 |
| Blood coagulation | ||||
| PT | 12.53 ± 2.12 | 12.21 ± 1.57 | 0.685 | 0.496 |
| APTT | 26.63 ± 2.99 | 28.66 ± 4.78 | -2.244 | 0.028 |
| Pathology | ||||
| Adenoma | 25 (51.02) | 12 (48.00) | 0.06 | 0.806 |
| Carcinoma in situ | 24 (48.98) | 13 (52.00) | ||
| Operation methods | ||||
| PD | 20 (40.82) | 17 (68.00) | 4.893 | 0.027 |
| EP | 29 (59.18) | 8 (32.00) | ||
- Citation: Xu L, Chen SJ, Wang P, Mao L, Zou XP, Wang L, Wang Y. Safety and efficacy of endoscopic papillectomy for duodenal papillary adenomas: A single-center retrospective study. World J Gastrointest Surg 2026; 18(2): 113698
- URL: https://www.wjgnet.com/1948-9366/full/v18/i2/113698.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v18.i2.113698